amifostine anhydrous has been researched along with Fracture, Pathologic in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tchanque-Fossuo, CN | 1 |
| Donneys, A | 1 |
| Sarhaddi, D | 1 |
| Poushanchi, B | 1 |
| Deshpande, SS | 1 |
| Weiss, DM | 1 |
| Buchman, SR | 1 |
2 other studies available for amifostine anhydrous and Fracture, Pathologic
| Article | Year |
|---|---|
The effect of Amifostine prophylaxis on bone densitometry, biomechanical strength and union in mandibular pathologic fracture repair.
Topics: Amifostine; Animals; Densitometry; Fractures, Spontaneous; Male; Mandible; Radiation-Protective Agen | 2013 |
Supportive care drug studies: some promising, some not.
Topics: Amifostine; Antineoplastic Agents; Cachexia; Clodronic Acid; Fractures, Spontaneous; Humans; Hydrazi | 1992 |